HIGHLIGHTS
- who: Ilhaam Abrahams et al. from the Department of Paediatrics Stellenbosch University, Cape Town, South Africa have published the research work: Colistin use in carbapenem-resistant Enterobacterales outbreak at South African neonatal unit, in the Journal: (JOURNAL) of 01/Dec/2018
- what: The authors found colistin to be safe in this cohort neonatal with no patient requiring treatment cessation because of adverse events.
SUMMARY
Preterm neonates, particularly those with underlying surgical conditions, those in to neonatal intensive care units (NICUs) and those with a history of prior antibiotic use, indwelling devices . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.